These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 21130145)

  • 1. Influence of nitric oxide agents in the rat amygdala on anxiogenic-like effect induced by histamine.
    Zarrindast MR; Nasehi M; Khansari M; Bananej M
    Neurosci Lett; 2011 Feb; 489(1):38-42. PubMed ID: 21130145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GABA and histamine interaction in the basolateral amygdala of rats in the plus-maze test of anxiety-like behaviors.
    Hajizadeh Moghaddam A; Roohbakhsh A; Rostami P; Heidary-Davishani A; Zarrindast MR
    Pharmacology; 2008; 82(1):59-66. PubMed ID: 18477857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of nitric oxide agents in the dorsal hippocampus of mice on anxiogenic-like effect induced by histamine.
    Piri M; Nasehi M; Asgariyan M; Zarrindast MR
    Pharmacol Biochem Behav; 2012 Sep; 102(3):391-9. PubMed ID: 22687724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide involvement and neural substrates of the conditioned and innate fear as evaluated in the T-maze test in rats.
    Calixto AV; Duarte FS; Moraes CK; Faria MS; De Lima TC
    Behav Brain Res; 2008 Jun; 189(2):341-9. PubMed ID: 18342958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of intra-amygdala injection of nicotine and GABA receptor agents on anxiety-like behaviour in rats.
    Zarrindast MR; Solati J; Oryan S; Parivar K
    Pharmacology; 2008; 82(4):276-84. PubMed ID: 18849647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of the dopaminergic receptors of the rat basolateral amygdala in anxiolytic-like effects of the cholinergic system.
    Zarrindast MR; Sroushi A; Bananej M; Vousooghi N; Hamidkhaniha S
    Eur J Pharmacol; 2011 Dec; 672(1-3):106-12. PubMed ID: 21968140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of nicotine on nitric oxide induced anxiogenic-like behaviors in the dorsal hippocampus.
    Piri M; Nasehi M; Shahab Z; Zarrindast MR
    Neurosci Lett; 2012 Oct; 528(2):93-8. PubMed ID: 22985517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intra-amygdaloid microinjection of neuropeptide glutamic acid-isoleucine induces anxiety-like behavior.
    Gastón S; Gargiulo PA; Bregonzio C; Baiardi G
    Neuroreport; 2011 Jan; 22(2):83-7. PubMed ID: 21164371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A role of nitric oxide mechanism involved in the protective effects of venlafaxine in sleep deprivation.
    Kumar A; Garg R
    Behav Brain Res; 2008 Dec; 194(2):169-73. PubMed ID: 18674568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of opioidergic system of the ventral hippocampus, the nucleus accumbens or the central amygdala in anxiety-related behavior.
    Zarrindast MR; Babapoor-Farrokhran S; Babapoor-Farrokhran S; Rezayof A
    Life Sci; 2008 Jun; 82(23-24):1175-81. PubMed ID: 18456284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of centrally-injected glucagon-like peptide-1 on pilocarpine-induced seizures, anxiety and locomotor and exploratory activity in rat.
    Gulec G; Isbil-Buyukcoskun N; Kahveci N
    Neuropeptides; 2010 Aug; 44(4):285-91. PubMed ID: 20227110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of ventral hippocampal nitric oxide/cGMP pathway in anxiety-related behaviors in rats submitted to the elevated T-maze.
    Calixto AV; Duarte FS; Duzzioni M; Nascimento Häckl LP; Faria MS; De Lima TC
    Behav Brain Res; 2010 Feb; 207(1):112-7. PubMed ID: 19800925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible nitric oxide modulation in protective effect of (Curcuma longa, Zingiberaceae) against sleep deprivation-induced behavioral alterations and oxidative damage in mice.
    Kumar A; Singh A
    Phytomedicine; 2008 Aug; 15(8):577-86. PubMed ID: 18586477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neonatal thyroxine treatment: changes in the number of corticotropin-releasing-factor (CRF) and neuropeptide Y (NPY) containing neurons and density of tyrosine hydroxylase positive fibers (TH) in the amygdala correlate with anxiety-related behavior of wistar rats.
    Yilmazer-Hanke DM; Hantsch M; Hanke J; Schulz C; Faber-Zuschratter H; Schwegler H
    Neuroscience; 2004; 124(2):283-97. PubMed ID: 14980379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of nitric oxide in insulin induced memory improvement.
    Choopani S; Moosavi M; Naghdi N
    Peptides; 2008 Jun; 29(6):898-903. PubMed ID: 18295375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local repeated corticotropin-releasing factor infusion exacerbates anxiety- and fear-related behavior: differential involvement of the basolateral amygdala and medial prefrontal cortex.
    Bijlsma EY; van Leeuwen ML; Westphal KG; Olivier B; Groenink L
    Neuroscience; 2011 Jan; 173():82-92. PubMed ID: 21093544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of ERK2 in basolateral amygdala underlies the promoting influence of stress on fear memory and anxiety: influence of midazolam pretreatment.
    Maldonado NM; Espejo PJ; Martijena ID; Molina VA
    Eur Neuropsychopharmacol; 2014 Feb; 24(2):262-70. PubMed ID: 24182621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of neurotensin in positive reinforcement in the rat central nucleus of amygdala.
    László K; Tóth K; Kertes E; Péczely L; Lénárd L
    Behav Brain Res; 2010 Apr; 208(2):430-5. PubMed ID: 20035801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anxiogenic-like effects induced by NMDA receptor activation are prevented by inhibition of neuronal nitric oxide synthase in the periaqueductal gray in mice.
    Miguel TT; Nunes-de-Souza RL
    Brain Res; 2008 Nov; 1240():39-46. PubMed ID: 18793618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of histaminergic agents in the ventral hippocampus of rats in the plus-maze test of anxiety-like behaviours.
    Rostami P; Hajizadeh-Moghaddam A; Zarrindast MR
    Physiol Behav; 2006 May; 87(5):891-6. PubMed ID: 16600315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.